Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bodhi Tree Biotechnology (BDTB) Net Income towards Common Stockholders (2024 - 2025)

Historic Net Income towards Common Stockholders for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q4 2025 value amounting to -$52948.0.

  • Bodhi Tree Biotechnology's Net Income towards Common Stockholders rose 1826.11% to -$52948.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$137837.0, marking a year-over-year change of. This contributed to the annual value of -$149666.0 for FY2025, which is N/A changed from last year.
  • Per Bodhi Tree Biotechnology's latest filing, its Net Income towards Common Stockholders stood at -$52948.0 for Q4 2025, which was up 1826.11% from -$10687.0 recorded in Q3 2025.
  • Bodhi Tree Biotechnology's Net Income towards Common Stockholders' 5-year high stood at -$10687.0 during Q3 2025, with a 5-year trough of -$64777.0 in Q4 2024.